Clinical Trial Update: Evaluation of Effectiveness of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A Against Invasive Disease [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating GSK's pneumococcal conjugate vaccine 1024850A for effectiveness against invasive pneumococcal disease; trial completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infections Streptococcal
• Invasive Pneumococcal Disease
• Streptococcus Pneumoniae Infection

Drugs mentioned

• Pneumococcal conjugate vaccine 1024850A

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Streptococcal, Streptococcus Pneumoniae | Phase 3 | Status: COMPLETED | Results posted: 2020-09-25